Azrieli Foundation’s Post

Can seminal plasma #extracellularvesicles #spEVs directly prime #Tcells for differentiation into regulatory T-cells (Tregs)? According to a recent paper by Xiaogang Zhang and colleagues, their work provides very informative insights into the #celltocell mechanisms by which spEVs can induce this T-cell differentiation. https://lnkd.in/gKKAcPZw

Beatrice S. is the Chief Scientific Officer of Altasciences, Her guidance, Altasciences has swiftly adapted, recognizing the unique attributes of psychedelic compounds, and developing safe and efficient clinical methods for their study in the early phases. Read More: https://cutt.ly/seT7uEV2 #DrugDevelopment #PharmaceuticalInnovation #DrugDiscovery #HealthcareAdvancements #MedicalResearch #PharmaLeaders #InsightsCare #healthcareinnovationmagazines

Schedule a meeting with our experts to discuss your upcoming product development, including Early Phase and Late Phase Trials. #Cliantha #clinicaltrials #clinicalresearch #drugdevelopment

The All of Us Research Program needs YOU to help make change possible. Consent to being part of that change. Learn more about the All of Us Research Program today at bit.ly/NPHCJoinAllofUs #joinallofus #bglc #apa1906network #medicalresearch #clickcreateconnectcommit

A master research agreement (MRA) allows a company to fund multiple research or clinical trial projects at the University over a period of time, making it easier to start new projects. In this 30-minute mini-webinar you will learn about the benefits of MRAs, when and how MRAs are used, and how to start a project under an MRA. Learn more and register for Master Research Agreements with Industry: https://bit.ly/4eCKFiO

ICTER is becoming ICTER CoE! The International Centre for Translational Eye Research (ICTER) is one of the winners of the prestigious "Teaming for Excellence" in the European Commission's Horizon Europe programme. Thanks to the funding of 15 million euros, a Centre of Excellence (ICTER CoE) will be established, operating at the Institute of Physical Chemistry, Polish Academy of Sciences and headed by Prof. Maciej Wojtkowski. The ICTER Centre of Excellence's goals, i.e. creating modern ophthalmic diagnostic tools to combat eye diseases affecting over 250 million people worldwide, will remain the same, but will now be pursued on an incomparably larger scale. More information about the newly established Centre of Excellence: https://lnkd.in/d8wD7aVq. #ICTER_PL #IPC_PAS #IChF #CentreofExcellence #TeamingforExcellence #Grant #Widening #HorizonEurope #EUFunds #EUCommision #Vision

Our team at NEXT Life Sciences, Inc. is proud to announce that we have concluded a successful clinical evaluation of a new delivery method for Plan A™! This new proprietary delivery method was evaluated by Michel Labrecque, MD PhD, a member of our Medical Advisory Board, and a globally-renowned medical doctor, professor, clinical researcher, and pioneer in the field of no-scalpel vasectomies. Following the evaluation, Dr. Labrecque concluded, "In both the formulation of its hydrogel and its unique delivery method, Plan A™ represents the evolution of a long line of research and advances in male contraceptive research.” Read more about this exciting update in the article on AP News here - https://buff.ly/3w9k5ww

Our team at NEXT Life Sciences, Inc. is proud to announce that we have concluded a successful clinical evaluation of a new delivery method for Plan A™! This new proprietary delivery method was evaluated by Michel Labrecque, MD PhD, a member of our Medical Advisory Board, and a globally-renowned medical doctor, professor, clinical researcher, and pioneer in the field of no-scalpel vasectomies. Following the evaluation, Dr. Labrecque concluded, "In both the formulation of its hydrogel and its unique delivery method, Plan A™ represents the evolution of a long line of research and advances in male contraceptive research.” Read more about this exciting update in the article on AP News here - https://buff.ly/3w9k5ww

🔬 Upcoming Session at #ALFC2024: Dr. Dan Siman-Tov, Senior Director of R&D at Meridian Bioscience Inc. We're looking forward to Dr. Dan Siman-Tov's insightful session at the Advanced #LateralFlow Conference. As the Senior Director of R&D in Diagnostics at Meridian Bioscience, Dr. Siman-Tov brings his extensive experience to his session titled "Lateral Flow Diagnostics: Challenges, Advantages, and Technical Guidelines." 🌟 Why This Session Is Crucial: Expert Insights: With Dr. Siman-Tov's extensive background in diagnostics, attendees will gain a comprehensive understanding of the current challenges and advantages in lateral flow technology. Practical Guidance: Learn about essential technical guidelines that are critical for developing and enhancing lateral flow diagnostic tests. Future Trends: Explore how the field is evolving and what we can expect in terms of innovation and application. 🤝 This session is perfect for professionals in R&D, quality assurance, and anyone involved in the development and application of lateral flow diagnostics. Don’t miss the opportunity to gain valuable knowledge from a leading expert in the field. 📅 Haven't registered yet? Registration ends February 9 and the hotel room block closes January 26! Register here: https://lnkd.in/emRskqjd #IVD #LFA #Diagnostics #Innovation #MeridianBioscience

Neuroethics Consulting Maybe I can get to this one! #bioethics #CBI #neuroethics #brainhealth #BCI #innovation #bioethics